Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery:
A Multicentre Clinical Trial

J 2021

Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery: A Multicentre Clinical Trial

ZATECKY, Jan, Otakar KUBALA, Oldřich COUFAL, Marketa KEPICOVA, Adela FARIDOVA et. al.

Basic information

Original name

Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery: A Multicentre Clinical Trial

Authors

ZATECKY, Jan (203 Czech Republic, guarantor), Otakar KUBALA (203 Czech Republic), Oldřich COUFAL (203 Czech Republic, belonging to the institution), Marketa KEPICOVA (203 Czech Republic), Adela FARIDOVA (203 Czech Republic), Karel RAUS (203 Czech Republic), Milan LERCH (203 Czech Republic), Matus PETEJA (203 Czech Republic) and Radim BRAT (203 Czech Republic)

Edition

BREAST CARE, BASEL, KARGER, 2021, 1661-3791

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30214 Obstetrics and gynaecology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 2.268

RIV identification code

RIV/00216224:14110/21:00124177

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1159/000510380

UT WoS

000688555500010

Keywords in English

Magseed; Magnetic marker; Breast cancer surgery; Tumour localisation; Axillary node localisation

Abstract

V originále

Introduction: The aim of this study was to evaluate the accuracy and reliability of the Magseed magnetic marker in breast cancer surgery. Methods: Thirty-nine patients with 41 implanted Magseeds undergoing surgical treatment in 3 surgical oncology departments were included in the retrospective trial to study pilot use of the Magseed magnetic marker in the Czech Republic for localisation of breast tumours or pathological axillary nodes in breast cancer patients. Results: Thirty-four breast cancer and 7 pathological lymph node localisations were performed by Magseed implantation. No placement failures, or perioperative detection failures of Magseeds were observed (0/41, 0.0%), but one case of Magseed migration was present (1/41, 2.4%). All magnetic seeds were successfully retrieved (41/41, 100.0%). Negative margins were achieved in 29 of 34 (85.3%) breast tumour localisations by Magseed. Conclusion: Magseed is a reliable marker for breast tumour and pathological axillary node localisation in breast cancer patients. Magseed is comparable to conventional localisation methods in terms of oncosurgical radicality and safety.

Citovat

ZATECKY, Jan, Otakar KUBALA, Oldřich COUFAL, Marketa KEPICOVA, Adela FARIDOVA, Karel RAUS, Milan LERCH, Matus PETEJA and Radim BRAT. Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery: A Multicentre Clinical Trial. BREAST CARE. BASEL: KARGER, 2021, vol. 16, No 4, p. 383-388. ISSN 1661-3791. Available from: https://dx.doi.org/10.1159/000510380.

@article{1834639,
   author = {Zatecky, Jan and Kubala, Otakar and Coufal, Oldřich and Kepicova, Marketa and Faridova, Adela and Raus, Karel and Lerch, Milan and Peteja, Matus and Brat, Radim},
   article_location = {BASEL},
   article_number = {4},
   doi = {http://dx.doi.org/10.1159/000510380},
   keywords = {Magseed; Magnetic marker; Breast cancer surgery; Tumour localisation; Axillary node localisation},
   language = {eng},
   issn = {1661-3791},
   journal = {BREAST CARE},
   title = {Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery: A Multicentre Clinical Trial},
   url = {https://www.karger.com/Article/FullText/510380},
   volume = {16},
   year = {2021}
}

TY  - JOUR
ID  - 1834639
AU  - Zatecky, Jan - Kubala, Otakar - Coufal, Oldřich - Kepicova, Marketa - Faridova, Adela - Raus, Karel - Lerch, Milan - Peteja, Matus - Brat, Radim
PY  - 2021
TI  - Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery: A Multicentre Clinical Trial
JF  - BREAST CARE
VL  - 16
IS  - 4
SP  - 383-388
EP  - 383-388
PB  - KARGER
SN  - 16613791
KW  - Magseed
KW  - Magnetic marker
KW  - Breast cancer surgery
KW  - Tumour localisation
KW  - Axillary node localisation
UR  - https://www.karger.com/Article/FullText/510380
N2  - Introduction: The aim of this study was to evaluate the accuracy and reliability of the Magseed magnetic marker in breast cancer surgery. Methods: Thirty-nine patients with 41 implanted Magseeds undergoing surgical treatment in 3 surgical oncology departments were included in the retrospective trial to study pilot use of the Magseed magnetic marker in the Czech Republic for localisation of breast tumours or pathological axillary nodes in breast cancer patients. Results: Thirty-four breast cancer and 7 pathological lymph node localisations were performed by Magseed implantation. No placement failures, or perioperative detection failures of Magseeds were observed (0/41, 0.0%), but one case of Magseed migration was present (1/41, 2.4%). All magnetic seeds were successfully retrieved (41/41, 100.0%). Negative margins were achieved in 29 of 34 (85.3%) breast tumour localisations by Magseed. Conclusion: Magseed is a reliable marker for breast tumour and pathological axillary node localisation in breast cancer patients. Magseed is comparable to conventional localisation methods in terms of oncosurgical radicality and safety.
ER  -

ZATECKY, Jan, Otakar KUBALA, Oldřich COUFAL, Marketa KEPICOVA, Adela FARIDOVA, Karel RAUS, Milan LERCH, Matus PETEJA and Radim BRAT. Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery: A Multicentre Clinical Trial. \textit{BREAST CARE}. BASEL: KARGER, 2021, vol.~16, No~4, p.~383-388. ISSN~1661-3791. Available from: https://dx.doi.org/10.1159/000510380.

Detailed Information on Publication Record